|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.66 EUR | +0.27% |
|
+0.41% | -10.94% |
| May. 08 | Eurobio Scientific: agreement with Myriad Genetics | CF |
| May. 08 | Eurobio Scientific to Buy Gene Expression Test for Breast Cancer | MT |
Diaxonhit announced the appointment of Thomas Iff as Chief Business Officer. Thomas is responsible for the global and strategic marketing of the group to accelerate specifically its international development. For over ten years, Thomas Iff held the position of International Marketing Director at Bio-Rad Laboratories.
Previously, he served as General Manager for Organon Teknika.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.94% | 163M | |
| +41.79% | 50.93B | |
| -0.56% | 42.12B | |
| +49.62% | 42.05B | |
| -7.20% | 29.18B | |
| +12.59% | 26.02B | |
| -21.51% | 18.9B | |
| +6.92% | 13.21B | |
| +24.91% | 12.17B | |
| +29.60% | 12.16B |
EUROBIO SCIENTIFIC 
